Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Authors
Keywords
Ulcerative Colitis, Inflammatory Bowel Disease, Infliximab, Vedolizumab
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-28
DOI
10.1016/j.cgh.2021.07.038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
- (2021) Dan Turner et al. GASTROENTEROLOGY
- First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis
- (2020) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
- (2020) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Long-term safety of vedolizumab for inflammatory bowel disease
- (2020) Edward V. Loftus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- ACG Clinical Guideline
- (2019) David T. Rubin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
- (2014) Axel Dignass et al. Journal of Crohns & Colitis
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
- (2009) Millie D. Long et al. Clinical Gastroenterology and Hepatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started